Moreover, in lung cancer [184], multiple myeloma [185], leukemias [186,187,188,189,190,191], and breast cancer stem cells [192], FTY720 mediates cancer cell death and tumor suppression via protein phosphatase 2A (PP2A)-dependent pathways. Here, PTPA is linked to neoplasm.